Associations of Sodium and Potassium with Obesity Measures Among Diverse US Hispanic/Latino Adults: Results from the Hispanic Community Health Study/Study of Latinos

Obesity (Silver Spring). 2018 Feb;26(2):442-450. doi: 10.1002/oby.22089. Epub 2018 Jan 10.

Abstract

Objective: The objective of this study was to evaluate cross-sectional associations of sodium and potassium with BMI, waist circumference (WC), and body fat and to determine whether the nativity and/or duration of United States (US) residence modified these associations.

Methods: Sodium and potassium were derived from 24-hour diet recalls from 16,156 US participants of the 2008 to 2011 Hispanic Community Health Study/Study of Latinos (HCHS/SOL) and from 24-hour urine in 447 HCHS/SOL participants. BMI, WC, and body fat were measured.

Results: Dietary sodium that was 500 mg/d higher was cross-sectionally associated with a 0.07-kg/m2 higher BMI (P < 0.05) and a 0.18-cm larger WC (P = 0.04). Dietary potassium that was 500 mg/d higher was only associated with lower BMI and smaller WC among those who were foreign-born with 10 + years in the US (-0.13 kg/m2 , P < 0.01 and -0.36 cm, P = 0.01, respectively) and among those who were US-born (-0.62 kg/m2 , P < 0.01 and -1.42 cm, P < 0.01, respectively). Urinary sodium that was 500 mg/d higher was associated with a 0.27-kg/m2 higher BMI (P < 0.01) and 0.54 kg more body fat (P < 0.01).

Conclusions: Sodium intake was associated with higher BMI, WC, and body fat. Potassium intake was associated with lower BMI and smaller WC among US-born participants and participants with a longer duration of US residence.

Trial registration: ClinicalTrials.gov NCT02060344.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Cross-Sectional Studies
  • Diet / methods*
  • Female
  • Hispanic or Latino
  • Humans
  • Male
  • Middle Aged
  • Potassium / pharmacology
  • Potassium / therapeutic use*
  • Public Health / methods*
  • Sodium / adverse effects*
  • Sodium / pharmacology
  • United States
  • Young Adult

Substances

  • Sodium
  • Potassium

Associated data

  • ClinicalTrials.gov/NCT02060344